drugset / Trial / NCT03382938
Dexmedetomidine Wound Infiltration in Cesarean Section
RandomizedParallel-groupDouble-blindPrevention
Summary
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).
Timeline
- Start
- 2019-08-23
- Primary completion
- 2025-12-20
- Completion
- 2026-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Subcutaneous |
| Comparator | Ropivacaine | Other / unclassified | 0.375 % | Subcutaneous |
Indications
No indication recorded.